DOH okays recruitment of Avigan trials participants; test may start next week
MANILA, Philippines — The clinical trials for Japanese anti-flu drug Avigan as a possible COVID-19 treatment may finally start next week as the Department of Health (DOH) gave the go signal for the recruitment of participants in the test.
In an online media forum Friday, Health Undersecretary Maria Rosario Vergeire said authorities are just attending to some “minor” issues into the insurance system of the clinical trials.
“Ang kulang nalang natin ‘yung insurance. May minor na comment ang legal service namin for this document. ‘Yun na lang but we already gave the go signal to the proponent, they can now start recruiting participants for the trials,” Vergeire told reporters.
“Kapag nakapag-recruit na tayo, hopefully, by next week talagang officially starting na tayo,” she added.
The Avigan trial was earlier slated to begin in mid-July but was delayed as legal arrangements were finalized. The Japanese government delivered in early August tablets enough for use by 100 patients.
The government has identified the Philippine General Hospital, Sta. Ana Hospital, Dr. Jose N. Rodriguez Memorial Hospital, and Quirino Memorial Medical Center as trial sites for the study.
As of October 8, there are 331,869 confirmed COVID-19 cases in the Philippines, including 274,318 recoveries and 6,069 deaths.
The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link .
Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.